Violation Tracker Individual Record

Company: 
Endo International plc
Current Parent Company: 
Endo International
Penalty: 
$2,300,000
Year: 
2019
Date: 
July 25, 2019
Offense Group: 
competition-related offenses
Primary Offense: 
price-fixing or anti-competitive practices
Violation Description: 

Endo International plc and Endo Pharmaceuticals Inc. agreed to pay $2.3 million to resolve multistate litigation alleging anti-competitive, "pay-for-delay" conduct related to Endo's sale of Lidoderm, a pain-relief drug that treats complications from shingles.

Level of Government: 
state
Action Type: 
agency action
Agency: 
Multistate Attorneys General Case
Civil or Criminal Case: 
civil
HQ Country of Parent: 
Ireland (reincorporated for tax reasons)
Ownership Structure of Parent: 
publicly traded
Major Industry of Parent: 
pharmaceuticals
Specific Industry of Parent: 
pharmaceuticals
Source Notes: 
If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.
Parent company note: 
Parent-subsidiary relationship is current as of the most recent revision listed in the Update Log.